| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2008 | US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors |
| 04/17/2008 | US20080090821 Improved solubility, lower tendency to bind to plasma proteins and greater activity especially in serum-based assay systems; remodeling of heart after myocardial infarction; atherosclerosis; 2-[4-(4-Fluorophenoxy)benzenesulfonyl]-6-(2-piperidin-1-ylethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid |
| 04/17/2008 | US20080090820 Novel crystalline form of linezolid |
| 04/17/2008 | US20080090819 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE |
| 04/17/2008 | US20080090818 (4-Morpholin-4-yl-phenyl)-[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]-amine; mitogen-activated protein kinase and matrix metallo proteinase inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis |
| 04/17/2008 | US20080090817 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090814 For treating infections by hepatitis C virus; 4-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-pyridazin-3-one 16 |
| 04/17/2008 | US20080090813 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 04/17/2008 | US20080090812 Pyrrolobenzodiazepine Therapeutic Agents Useful in the Treatment of Leukemias |
| 04/17/2008 | US20080090811 Carbamate compounds as 5-HT4 receptor agonists |
| 04/17/2008 | US20080090810 Thiophene compounds |
| 04/17/2008 | US20080090809 Pyrazole compounds |
| 04/17/2008 | US20080090808 Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction |
| 04/17/2008 | US20080090807 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/17/2008 | US20080090806 (Calcitonin gene related peptide); azepinone ligands; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide; analgesic, antiinflammatory agent; migranes, arthritis, neurodegenerative diseases |
| 04/17/2008 | US20080090805 Cb-1 modulating compounds and their use |
| 04/17/2008 | US20080090804 (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine derivatives; contraception, hormone replacement therapy (HRT) or gynaecological disorders, adjuvant therapy in cancer |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090802 2-[2-(3-Chlorophenyl)-4-oxo-6-perhydro-1,4-diazepin-1-yl-4H-quinazolin-3-yl]-N-isopropylacetamide; hypothalamo-pituitary-adrenal (HPA) axis stress relieving agent; adrenocorticotropic hormone (ACTH)/ glucocorticoid antagonist; psychological and bipolar disorders, schizophrenia, psychosis, hyperactivity |
| 04/17/2008 | US20080090801 2-amino-8-(trans-4-hydroxycyclohexyl)-4-methyl-7-oxo-N-1H-pyrazol-5-yl-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide; anticarcinogenic; phosphoinositide 3-kinase alpha (PI3-K alpha ) inhibitor; cell cycle regulation, proliferation, apoptosis; inhibit resistance to cytotoxic agents in cancer cells |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | US20080090799 2-pyridinecarboxamide derivative having gk-activating effect |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090796 Useful in the treatment of neurological and psychiatric disorders associated with glutamatergic neurotransmission dysfunction and diseases; schizophrenia; 2,4-dichloro-N-{[4-(cyclopropylmethyl)-1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl]methyl}benzamide |
| 04/17/2008 | US20080090795 Pharmaceutical Compositions Based on Nk2 Antagonists for Pediatric Use |
| 04/17/2008 | US20080090794 Potassium Channel Inhibitors |
| 04/17/2008 | US20080090793 Compounds and methods for the treatment of cancer |
| 04/17/2008 | US20080090792 Selective glucocorticoid receptor agonists |
| 04/17/2008 | US20080090791 3 beta -hydroxy-16 alpha -fluoro-17 beta -aminoandrost-5-ene; immunostimulant, antiinflammatory agent; neutropenia, infections, blood cell deficiencies; interleukin, tumor necrosis factor, macrophage inflammatory protein, transforming growth factor, cyclooxygenase, and lipoxygenase inhibitor |
| 04/17/2008 | US20080090790 Pharmaceutical composition comprising a corticosteroid and a specific inhibitor of hedgehog/smoothened signaling |
| 04/17/2008 | US20080090789 Tigecycline crystalline forms and processes for preparation thereof |
| 04/17/2008 | US20080090788 Chemical Compounds |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090786 Atherosclerosis; ethyl (E)-2-(4-hydroxy-3-methoxyphenyl)vinyl-phosphonofluoridoate; fluorination of organophosphorus compounds, including organothiophosphorus compounds, to form corresponding fluoro(thio)phosphorus compounds |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | US20080090784 Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it |
| 04/17/2008 | US20080090783 LPA Receptor Agonists and Antagonists and Methods of Use |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | US20080090781 Formulations Containing Alkylphosphocholines Using Novel Negative Charge Carriers |
| 04/17/2008 | US20080090779 2-Benzyloxy-5-(2-bromoacetyl)-N-[3,5-bis(trifluoromethyl)phenyl-benzamide; diseases caused by production of immunoglobulin E: inflammatory cytokine, histamine, leukotriene and degranulation from activated mast cell; pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis, hysteromyoma |
| 04/17/2008 | US20080090778 Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| 04/17/2008 | US20080090777 Long lasting drug formulations |
| 04/17/2008 | US20080090776 Obtained from lung cancer patients; cDNA and genomic DNA of a novel fusion polynucleotide of an EML4 gene fused with an ALK gene as kinase (EML4-ALK fusion polynucleotide variant 1); for screening a therapeutic agent for cancer, treating cancer |
| 04/17/2008 | US20080090775 Antagonist of TEB4 and Methods of Use |
| 04/17/2008 | US20080090774 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| 04/17/2008 | US20080090773 Antibacterial activity; 4''-O-{3-[3-(3-Carboxy-1,4-dihydro-1-dimethylamino-4-oxo-6-quinolinyl)propylamino]propionyl}-6-O-methylerythromycin A |
| 04/17/2008 | US20080090772 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 04/17/2008 | US20080090771 Modification of pharmacokinetic and pharmacological properties of hydrocodone through covalent modification by conjugating hydrocodone with a carrier selected from an amino acid, a dipeptide, a tripeptide, a tetrapeptide and a pentapeptide; analgesic; bioavailability |
| 04/17/2008 | US20080090759 Methods and kits for predicting risk for preterm labor |
| 04/17/2008 | US20080090752 Anti-tumor vasculature effects of human serum albumin derivatives |
| 04/17/2008 | US20080090749 Prophylactic/therapeutic agent for stress-induced bowel disease |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090000 From olives; incubating the acidified water until at least 75 percent of oleoeuropein has been converted to hydroxytyrosol; nutraceuticals in tablet, capsule, pill or confection form; antioxidants |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089963 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 04/17/2008 | US20080089962 Nutritional composition for facilitating muscle pumps |
| 04/17/2008 | US20080089959 Composition and uses of galectin antagonists |
| 04/17/2008 | US20080089958 Dermo-cosmetic compositions for topical and intravaginal application for treatment of human and veterinary affections caused by anaerobic organisms; vaginitis |
| 04/17/2008 | US20080089956 Nitric oxide in treatment of inflammation |
| 04/17/2008 | US20080089954 Diagnosis and treatment of human dormancy syndrome |
| 04/17/2008 | US20080089953 Multi-dose; no conventional preservatives; also comprises borate/propylene glycol, borate/glycerol |
| 04/17/2008 | US20080089952 Compositions and methods for coating medical implants |
| 04/17/2008 | US20080089950 Lymphoid tissue inducers and an immunomodulatory agent; proliferative disorders, infectious diseases, cardiovascular diseases, inflammatory disorders and autoimmune disorders |
| 04/17/2008 | US20080089947 Calcium Influx Inhibitors in the Treatment of Ischemia |
| 04/17/2008 | US20080089945 Administering a composition comprising beeswax at a concentration of 1%-20% by weight, a fatty acid-containing oil at a concentration of at least 10% by weight and a sterol compound at a concentration of at least 1% by weight |
| 04/17/2008 | US20080089943 Use of adsorbent carbon microspheres to treat gastroesophogeal reflux disease |
| 04/17/2008 | US20080089941 Fucoidan compositions and methods |
| 04/17/2008 | US20080089939 Dermastick thickened ointment |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089936 Prolonged release formulation of active principles having a ph-dependent solubility |
| 04/17/2008 | US20080089935 Stable Solid Dispersion Of A Derivative Of Vinca Alkaloid And Process For Manufacturing It |
| 04/17/2008 | US20080089934 Soft capsules, solid dosage forms; heating, hydrating, mixing, solubilizing a high solids, low moisture film-forming mixture to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature, feeding into pump, cooling; thermoreversible gel films |
| 04/17/2008 | US20080089932 Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome |
| 04/17/2008 | US20080089931 EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders |
| 04/17/2008 | US20080089927 High drug to lipid ratio |
| 04/17/2008 | US20080089926 Formed of isoprene-styrene block copolymer; improved skin permeability and lower irritation |
| 04/17/2008 | US20080089925 Drug for External Use and Adhesive Patch |
| 04/17/2008 | US20080089924 Metastasis inhibitors; foods |
| 04/17/2008 | US20080089919 Such as heparin cofactor II binding activity; antithromin |
| 04/17/2008 | US20080089918 Biocompatible; surgical auxiliaries, temporary implants, and hydration implants |
| 04/17/2008 | US20080089915 Use of a specific inhibitor of hedgehog/smoothened signaling on hyperpigmented skin to obtain decrease of pigmentation |
| 04/17/2008 | US20080089914 mixing aqueous Solution "A" containing a salt of an organic acid ( sodium citrates, sodium glylcolate, sodium lactate) in presence of a reducing salt of sodium metabisulfites or sodium hydrosulfites with Solution "B" containing aqueous solution of a water soluble H2O2; pH control; antiacne, fungicide |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089910 Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof |
| 04/17/2008 | US20080089909 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1 |
| 04/17/2008 | US20080089901 Hivcon: an hiv immunogen and uses thereof |
| 04/17/2008 | US20080089896 Bivalent SMAC mimetics and the uses thereof |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089894 Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089884 For treating and/or preventing bladder disorders; for decreasing the expression, release or biological activity of macrophage migration inhibition factor |
| 04/17/2008 | US20080089883 Antisense oligonucleotides for prevention and/or treatment of infection, asthma, skin, inflammatory and/or autoimmune disorders |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089881 Using nicotinic acid receptor (HM74) as diagnostic and evaluative tool in detection of psoraisis, ulcerative colitis, multiple sclerosis, irratable bowel and/or , crohn's diseases |
| 04/17/2008 | US20080089877 Super Absorption Coenzyme Q10 |
| 04/17/2008 | US20080089876 Mixture comprising an omega three fatty acid, statin, coenzyme Q10, resveratrol, at least one policosanol, pantethine, selenium, and zinc for use in treatment and prevention of diabetes, obesity, hypertension, hyperlipidaemias and hypercholesterolaemias |